Enhanced cellular uptake of lactosomes using cell-penetrating peptides

被引:15
作者
Akahoshi, Akiya [1 ]
Matsuura, Eiji [2 ]
Ozeki, Eiichi [3 ]
Matsui, Hayato [3 ]
Watanabe, Kazunori [1 ]
Ohtsuki, Takashi [1 ]
机构
[1] Okayama Univ, Dept Med Bioengn, Okayama 7008530, Japan
[2] Okayama Univ, OMIC, Collaborat Res Ctr, Okayama 7008558, Japan
[3] Shimadzu Co Ltd, Technol Res Lab, Kyoto, Japan
关键词
Cell penetrating peptide; polymeric micelle; drug delivery; photosensitizer; lactosome; POLYMERIC MICELLES; IN-VIVO; DRUG-DELIVERY; MULTIPLE ADMINISTRATIONS; CLINICAL-APPLICATIONS; MAMMALIAN-CELLS; TAT PROTEIN; CANCER; ACCUMULATION; PROGRESS;
D O I
10.1080/14686996.2016.1178056
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
Polymeric micelles that are composed of synthetic polymers are generally size controllable and can be easily modified for various applications. Lactosomes (A(3)B-type) are biodegradable polymeric micelles composed of an amphipathic polymer, including three poly(sarcosine) blocks and a poly(L-lactic acid) block. Lactosomes accumulate in tumors in vivo through the enhanced permeability and retention (EPR) effect, even on frequently administering them. However, lactosomes cannot be efficiently internalized by cells. To improve cellular uptake of lactosomes, cell-penetrating peptide (CPP)-modified lactosomes were prepared. Seven CPPs (including EB1 and Pep1) were used, and most of them improved the cellular uptake efficiency of lactosomes. In particular, EB1- and Pep1-modified lactosomes were efficiently internalized by cells. In addition, by using CPP-modified and photosensitizer-loaded lactosomes, we demonstrated the photoinduced killing of mammalian cells, including human cancer cells. Accumulation of the EB1-modified lactosomes in NCI-N87 tumors was shown by in vivo imaging. Thus, this study demonstrated that the CPP-modified lactosome is a promising drug carrier. [GRAPHICS] .
引用
收藏
页码:245 / 252
页数:8
相关论文
共 29 条
[1]   Liposomal drug delivery systems: From concept to clinical applications [J].
Allen, Theresa M. ;
Cullis, Pieter R. .
ADVANCED DRUG DELIVERY REVIEWS, 2013, 65 (01) :36-48
[2]   Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future [J].
Arvizo, Rochelle R. ;
Bhattacharyya, Sanjib ;
Kudgus, Rachel A. ;
Giri, Karuna ;
Bhattacharya, Resham ;
Mukherjee, Priyabrata .
CHEMICAL SOCIETY REVIEWS, 2012, 41 (07) :2943-2970
[3]  
Cabral H, 2011, NAT NANOTECHNOL, V6, P815, DOI [10.1038/nnano.2011.166, 10.1038/NNANO.2011.166]
[4]   Progress of drug-loaded polymeric micelles into clinical studies [J].
Cabral, Horacio ;
Kataoka, Kazunori .
JOURNAL OF CONTROLLED RELEASE, 2014, 190 :465-476
[5]  
Canete M, 1998, INT J ONCOL, V13, P497
[6]   Cell-Penetrating Peptides: Design, Synthesis, and Applications [J].
Copolovici, Dana Maria ;
Langel, Kent ;
Eriste, Elo ;
Langel, Ulo .
ACS NANO, 2014, 8 (03) :1972-1994
[7]   Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules [J].
De Coupade, C ;
Fittipaldi, A ;
Chagnas, V ;
Michel, M ;
Carlier, S ;
Tasciott, E ;
Darmon, A ;
Ravel, D ;
Kearsey, J ;
Giacca, M ;
Cailler, F .
BIOCHEMICAL JOURNAL, 2005, 390 :407-418
[8]   Biodegradable polymeric micelles for targeted and controlled anticancer drug delivery: Promises, progress and prospects [J].
Deng, Chao ;
Jiang, Yanjiao ;
Cheng, Ru ;
Meng, Fenghua ;
Zhong, Zhiyuan .
NANO TODAY, 2012, 7 (05) :467-480
[9]   Current Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines [J].
Durymanov, Mikhail O. ;
Rosenkranz, Andrey A. ;
Sobolev, Alexander S. .
THERANOSTICS, 2015, 5 (09) :1007-1020
[10]   Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape [J].
Endoh, Tamaki ;
Ohtsuki, Takashi .
ADVANCED DRUG DELIVERY REVIEWS, 2009, 61 (09) :704-709